Detalles de la búsqueda
1.
Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors.
Cells
; 13(10)2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38786089
2.
Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival.
Cells
; 12(7)2023 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37048111
3.
Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2MUT ovarian cancer cells.
Sci Rep
; 13(1): 22659, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114660
4.
PARP inhibitor resistance in ovarian cancer: Underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway.
Biochim Biophys Acta Rev Cancer
; 1876(2): 188633, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34619333
5.
Lysophosphatidylcholine Containing Anisic Acid Is Able to Stimulate Insulin Secretion Targeting G Protein Coupled Receptors.
Nutrients
; 12(4)2020 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32331428
Resultados
1 -
5
de 5
1
Próxima >
>>